Copy
CINP Neurotransletter - Vol. 2 / Issue 3
Looking back with Dr. Alan Frazer
Dr. Alan Frazer has served a as Editor-in-Chief of the IJNP since 2008 and will be turning over the reins this June to Dr. Anthony Grace. In the following, he has highlighted some articles published in the journal during his term.

The CINP Executive Committee would like to sincerely thank Dr. Alan Frazer for his services and all the work he did for our journal! The very familiar and close contact with him was just one of the items that made the journal what it is today.
Please click on the button below to read his forward as he reflects on his 12-year term as Editor-in-Chief of the International Journal of Neuropsychopharmacology.
Collection by Dr. Alan Frazer
Subscribe to the CINP Newsletter
Did you receive this month's Neurotransletter into your inbox? If this was not the case, you are also missing out on several other e-mails we send out about the latest updates on the annual World Congress, Awards, Elections, Membership and more.
Make sure to click on the button below to subscribe to our newsletters!
Subscribe now!
Neuroscience-based Nomenclature
Together with representatives from ECNP, ACNP, AsCNP, and IUPHAR, a task force was formed to address a longstanding concern within the neuropsychopharmacological community that the nomenclature of psychotropic drugs did not properly reflect the underlying neuroscience of these compounds.
The Neuroscience-based Nomenclature (NbN) is a publication and a digital application of psychiatric medications classified by their pharmacology and mode of action. The NbN is updated on a yearly basis, equipping clinician with the latest insights in neuroscience in a way that can be applied in treatment on a daily basis. Read more.
Throwback to the most popular CINP Videos
In 2019, we released a videos series called 'CINP Leader Panel', who met at the 2019 International Meeting in Athens, Greece. The expert panel is joined by the following experts:
  • Siegfried Kasper, Medical University of Vienna, Austria
  • Gabriella Gobbi, McGill University, Canada
  • John Krystal, Yale University School of Medicine, USA
  • Carol Tamminga, UT Southwestern Medical Center, USA
You can click on the video below to watch the third part of this panel on new treatments for treatment-resistant depression.

Literature Updates

Please find the latest literature updates below.

  • Brain Functional Connectivity Correlates of Response in the 7.5% CO2 Inhalational Model of Generalized Anxiety Disorder: A Pilot Study - Read more.
     
  • Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants - Read more.
     
  • Neurocognitive markers of suicidal ideation in patients with anxiety and mood disorders - Read more.
     
  • BLOG: COVID-19: Potential Implications for Individuals with Substance Use Disorders - Read more.
Twitter
Facebook
Website
YouTube
LinkedIn
Copyright © CINP All rights reserved.

Our mailing address is:

Nußdorfer Straße 20/24
1090 Vienna
Vienna, Austria

Tel: (+43) 1 3532024
Fax: (+ 1) 604 681 1049


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.